Consequently, the inhibition of cell invasion and migration by this Src inhibitor is related to the downregulation of those genes and probably other oncogenes that might be involved in this process through β-catenin's role conversion in human cervical cancer cells expressing E6/E7 oncoproteins of high-risk HPV. This evidence concerns the gene SRC and cervical cancer.